Racial Differences in the Prevalence of Autism Spectrum Disorder: A Systematic Review
- PMID: 38941049
- PMCID: PMC12367818
- DOI: 10.1007/s10803-024-06403-5
Racial Differences in the Prevalence of Autism Spectrum Disorder: A Systematic Review
Abstract
Purpose: Racial differences in prevalence rates of autism spectrum disorder (ASD) have shifted in the United States (US) since the 1990s. This review addresses the nature and context of this shift and discusses potential contributing factors and areas for future research.
Methods: Seventeen population-based epidemiological birth cohort studies on ASD prevalence in the US that included race as a variable are included in the review. Studies were identified via a keyword search on PubMed. To be included, studies were required to include race or ethnicity as a variable in the prevalence estimates, include at least 1000 cases with autism, and be published in English by June 3rd, 2023.
Results: Results suggest that in nearly all birth cohorts prior to 2010, ASD prevalence rates were highest among White children. ASD prevalence rates among Black, Hispanic, and Asian/Pacific Islander (API) children (22.3, 22.5, and 22.2 per 1000, respectively) surpassed prevalence rates among White children (21.2 per 1000) in the 2010 birth cohort and continued to increase in the 2012 birth cohorts.
Conclusions: There are persistent racial differences in ASD prevalence in the US, and these differences were inverted after 2010, when ASD prevalence among Black, Hispanic, & API children surpassed ASD prevalence among White children. Possible drivers of this racial repatterning of ASD prevalence include changes in ASD screening and diagnosis, changes to health insurance policy, changes to immigration policy, and increased education attainment by minority groups.
Keywords: Autism spectrum disorder; Epidemiology; Ethnicity; Pervasive developmental disorder; Prevalence; Racial disparities.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Conflict of Interest: AK is on the Advisory Board for the Klingenstein Third Generation Foundation, Ovid Therapeutics, David Lynch Foundation, ADNP Kids Research Foundation, and Ritrova Therapeutics and consults to Acadia, Alkermes, Jaguar Therapeutics, GW Pharmaceuticals, Neuren Pharmaceuticals, Clinilabs Drug Development Corporation, Scioto Biosciences, and Biogen. The remaining authors have no potential conflict of interests related to this publication.
Figures


References
-
- Akinhanmi, M. O., Biernacka, J. M., Strakowski, S. M., McElroy, S. L., Berry, B., Merikangas, J. E., Assari, K. R., McInnis, S., Schulze, M. G., LeBoyer, T. G., Tamminga, M., Patten, C., C., & Frye, M. A. (2018). Racial disparities in bipolar disorder treatment and research: A call to action. Bipolar Disorders, 20(6), 506–514. 10.1111/bdi.12638. - PMC - PubMed
-
- American Psychiatric Association (1987). Pervasive Developmental Disorders. In Diagnostic and Statistical Manual of Mental Disorders (3rd edition-revised (DSM-III-R)).
-
- American Psychological Association (2000). Pervasive Developmental Disorders. In Diagnostic and Statistical Manual of Mental Disorders (4th edition-text revision (DSM-IV-TR), pp. 69–70).
-
- American Psychological Association (2013). Autism Spectrum Disorder. In Diagnostic and Statistical Manual of Mental Disorders (5th ed.). https://www.apa.org/topics/autism-spectrum-disorder.
-
- American Psychiatric Association (1994). Pervasive Developmental Disorders. In Diagnostic and Statistical Manual of Mental Disorders (4th ed.).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical